Tuberculosis trials consortium services

Active Definitive Contract Awarded Last action

Contract number
75D30121C10167
Awardee
Awarding agency
Obligated
$9,144,882

Award facts

Opportunity
Contract value 68% obligated
  • $9,219,881.79 Current, with exercised options
  • $13,523,501.30 Potential, with all options
Completion date 59% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 22 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Montreal, QC H3H, Canada

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00012 $1,424,245
Other Administrative Action P00011 · EO 14398 $0
Exercise an Option P00010 $1,380,829
Exercise an Option P00009 $1,320,761
Supplemental Agreement for work within scope P00008 $75,000
Exercise an Option P00007 $1,235,321
Exercise an Option P00006 $1,330,095
Supplemental Agreement for work within scope P00005 $0
Other Administrative Action P00004 $0
Exercise an Option P00003 $1,280,718
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $1,097,914
Show all 13

About this award

The Centers for Disease Control and Prevention awarded a $13.5 million ceiling cost-no-fee definitive contract to The Research Institute Of The Mcgill University Health Centre for Tuberculosis Trials Consortium clinical research services on December 17, 2020, with no set-aside used. The contract runs through December 31, 2030, with place of performance in Montreal, Quebec, Canada. The originating pre-solicitation, posted February 5, 2020 with responses due February 14, 2020, seeks ten years of clinical research support for tuberculosis treatment, diagnosis, and prevention trials. Requirements include participation in clinical research studies, adherence to study start-up procedures, and membership in the Tuberculosis Trials Consortium as a member site. Evaluation weighs a vendor's ability to run multiple trials concurrently under approved protocols. The government estimated up to four new studies between the base year and ninth option year, with zero to two new studies per phase plus enrollment, treatment, testing, and follow-up for multiple protocols.

The Service Contract Inventory reports FY2024 labor of 3.0 FTEs and 6,196 contractor hours, with $1.2 million invoiced and a derived government-paid rate of $188.82 per hour. FY2021 showed $86 thousand invoiced, 0.9 FTEs, 1,779 hours, and a rate of $48.39 per hour, so the rate is rising. FY2021 reporting covers civilian agencies only, while later years are government-wide, so cross-year comparisons are approximate. The prime self-performed all reported FY2024 hours, with no subcontractors reported.

Quick answers

Who was awarded contract 75D30121C10167?

75D30121C10167 was awarded to The Research Institute Of The Mcgill University Health Centre by CDC Pittsburgh (Centers for Disease Control and Prevention) on December 17, 2020.

How much is contract 75D30121C10167 worth?

The government has obligated $9,144,882 on 75D30121C10167. Its current value, with exercised options, is $9,219,882. Its potential value, with all options, is $13,523,501.

Was contract 75D30121C10167 competed?

The extent of competition for 75D30121C10167 was full and open competition. The government received 22 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award